Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis

被引:0
|
作者
Tjalf Ziemssen
机构
[1] Technical University of Dresden,Neurological University Clinic
[2] Medical Faculty “Carl Gustav Carus”,undefined
来源
Journal of Neurology | 2005年 / 252卷
关键词
multiple sclerosis; neurodegeneration; neuroprotection; inflammation; treatment;
D O I
暂无
中图分类号
学科分类号
摘要
Historically considered to be an autoimmune demyelinating disease, multiple sclerosis is now recognized to be characterized by significant axonal and neuronal pathology. Addressing this neurodegenerative component of the disease is an important treatment objective, since axonal injury is believed to underlie the accumulation of disability and disease progression. The precise relationship between the inflammatory and neurodegenerative components in multiple sclerosis remains poorly elucidated, although neurodegeneration appears to be at least partially independent from neuroinflammation. The mechanisms underlying axonal injury appear complex and are likely to be multifactorial. Specific treatment strategies need to be developed that act within the central nervous system to prevent neurodegeneration and need to be provided from the earliest stages of disease. It is likely that immunomodulatory treatments acting purely in the periphery will provide only indirect and not direct neuroprotection. A promising approach is to enhance neuroprotective autoimmunity inside the brain, believed to be mediated, at least in part, by the release of neurotrophic factors within the nervous system from infiltrating immune cells. Such a beneficial process would be inhibited by a non-selective immunosuppressive strategy. In summary, treatments of multiple sclerosis should take into account the heterogeneous pathophysiology of the disease. The pathogenic process in the central nervous system itself should be the major focus in multiple sclerosis therapy in order to protect against demyelination and axonal loss and to promote remyelination and regeneration directly in the target tissue, independently of peripheral immune status. In conclusion, selective treatment strategies aimed at preventing axonal injury within the central nervous system are required to complement existing, peripherally acting treatments targeting the immune system.
引用
收藏
页码:v38 / v45
相关论文
共 50 条
  • [31] AUTOANTIBODIES TO MYELIN BASIC-PROTEIN WITHIN MULTIPLE-SCLEROSIS CENTRAL-NERVOUS-SYSTEM TISSUE
    WARREN, KG
    CATZ, I
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1993, 115 (02) : 169 - 176
  • [32] Differences in systemic and central nervous system cellular immunity relevant to relapsing–remitting multiple sclerosis
    M. Matsui
    S.–i. Araya
    H.–Y. Wang
    K. Matsushima
    T. Saida
    Journal of Neurology, 2005, 252 : 908 - 915
  • [33] The ambivalent nature of T-cell infiltration in the central nervous system of patients with multiple sclerosis
    Vanderlocht, Joris
    Hellings, Niels
    Hendriks, Jerome J. A.
    Stinissen, Piet
    CRITICAL REVIEWS IN IMMUNOLOGY, 2007, 27 (01) : 1 - 13
  • [34] Magnetic resonance imaging surrogates of multiple sclerosis pathology and their relationship to central nervous system atrophy
    Meier, DS
    Weiner, HL
    Khoury, SJ
    Guttmann, CRG
    JOURNAL OF NEUROIMAGING, 2004, 14 (03) : 46S - 53S
  • [35] Role of inflammation and apoptosis in multiple sclerosis: Comparative analysis between the periphery and the central nervous system
    Macchi, Beatrice
    Marino-Merlo, Francesca
    Nocentini, Ugo
    Pisani, Valerio
    Cuzzocrea, Salvatore
    Grelli, Sandro
    Mastino, Antonio
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 287 : 80 - 87
  • [36] PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA IMITATES MULTIPLE-SCLEROSIS
    DEANGELIS, LM
    JOURNAL OF NEURO-ONCOLOGY, 1990, 9 (02) : 177 - 181
  • [37] Exercise in multiple sclerosis and its models: Focus on the central nervous system outcomes
    Guo, Ling Yi
    Lozinski, Brian
    Yong, Voon Wee
    JOURNAL OF NEUROSCIENCE RESEARCH, 2020, 98 (03) : 509 - 523
  • [38] Primary central nervous system lymphoma in a patient with multiple sclerosis using fingolimod
    Morillos, Matheus Bernardon
    Pires de Aguiar, Paulo Henrique
    Franceschini, Paulo Roberto
    Duarte, Juliana Avila
    Piccini, Cristian Daniel
    Finkelsztejn, Alessandro
    NEUROLOGICAL SCIENCES, 2023, 44 (01) : 361 - 363
  • [39] Immunological disturbances in the central nervous system linked to MRI findings in multiple sclerosis
    Wang, HY
    Matsui, M
    Saida, T
    JOURNAL OF NEUROIMMUNOLOGY, 2002, 125 (1-2) : 149 - 154
  • [40] Magnetization transfer MRI in multiple sclerosis and other central nervous system disorders
    Filippi, M
    EUROPEAN JOURNAL OF NEUROLOGY, 2003, 10 (01) : 3 - 10